RAB3IP (Gene)

Synonyms:ENTREZ:117177, HGNC:16508, MIM:608686, NM_001024647, NM_001278402, NM_022456, NM_175623, NM_175624, NM_175625, NM_175626, NM_175627, NP_001019818, NP_001265331, NP_071901, NP_783322, NP_783323, NP_783324, NR_103519, NR_103520, RAB3A interacting protein, RAB3IP, RABIN3, RABIN8, XM_006719226, XM_006719227, XM_017018773, XM_017018774, XM_017018775, XM_017018777, XM_024448832, XP_006719289, XP_006719290, XP_016874262, XP_016874263, XP_016874264, XP_016874266, XP_024304600, XR_001748572, XR_944487, XR_944488, XR_944489, XR_944490, XR_944491, XR_944492
Omim:OMIM:608686
Id:0d2eaab8-eb5b-5145-a5f7-86b7cf7a2f68
Hgnc:HGNC:16508
Entrez:117177
Description:RAB3A interacting protein
Enables guanyl-nucleotide exchange factor activity and identical protein binding activity. Involved in cilium assembly; protein localization to organelle; and protein targeting to membrane. Located in centrosome; cytosol; and nucleus. [provided by Alliance of Genome Resources, Apr 2022]

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View RAB3IP's neighborhood in the knowledge graph.

Playbook Workflow Builder
Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with RAB3IP.

Gene Partnership Appyter
CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using RAB3IP.

Gene and Drug Landing Page Aggregator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for RAB3IP.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with RAB3IP.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.